Congress makes critical decisions about the future of ALS research through the annual appropriations process. Our top advocacy priority each year aims to increase federal funding to support research and the search for treatments and cures for ALS. Federal funding for ALS research and programs at the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Department of Defense ALS Research Program and the Centers for Disease Control (CDC) National ALS Registry must be increased exponentially to provide new treatment options to cure and prevent ALS. 

ALS House champions—Representatives Jason Crow (D-CO) and Brian Fitzpatrick (R-PA) released their letter with the goal of enlisting their colleagues in the House in our fight.

Read the House Letter